MEVIS MEDSOL N - Dusseldorf Stock Exchang
MEVIS MEDSOL N - Dusseldorf Stock Exchang operates in Diversified Metals & Mining.
MEVIS MEDSOL N - Dusseldorf Stock Exchang (M3V) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2019: 0.069x
Based on the latest financial reports, MEVIS MEDSOL N - Dusseldorf Stock Exchang (M3V) has a cash flow conversion efficiency ratio of 0.069x as of June 2019.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€2.60 Million) by net assets (€37.83 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
MEVIS MEDSOL N - Dusseldorf Stock Exchang - Cash Flow Conversion Efficiency Trend (2017–2023)
This chart illustrates how MEVIS MEDSOL N - Dusseldorf Stock Exchang's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
MEVIS MEDSOL N - Dusseldorf Stock Exchang Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of MEVIS MEDSOL N - Dusseldorf Stock Exchang ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
The Yumy Candy Company Inc
OTCQB:YUMFF
|
0.001x |
|
FRIO3F
SA:FRIO3F
|
N/A |
|
Prima Moda SA
WAR:PMA
|
0.241x |
|
CBRAIN
BE:C6F
|
N/A |
|
Boussard & Gavaudan Holding Limited
LSE:BGHL
|
-0.004x |
|
UPSD
BATS:UPSD
|
N/A |
|
CompuLab Ltd
TA:CLAB
|
0.080x |
|
ANGLO AMERICAN
MU:NGLB
|
N/A |
Annual Cash Flow Conversion Efficiency for MEVIS MEDSOL N - Dusseldorf Stock Exchang (2017–2023)
The table below shows the annual cash flow conversion efficiency of MEVIS MEDSOL N - Dusseldorf Stock Exchang from 2017 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-09-30 | €17.83 Million | €5.85 Million | 0.328x | +20.52% |
| 2022-09-30 | €17.83 Million | €4.86 Million | 0.272x | -46.80% |
| 2021-09-30 | €17.83 Million | €9.13 Million | 0.512x | +215.97% |
| 2020-09-30 | €17.83 Million | €2.89 Million | 0.162x | -55.84% |
| 2019-09-30 | €17.83 Million | €6.54 Million | 0.367x | +113.19% |
| 2018-09-30 | €32.06 Million | €5.52 Million | 0.172x | -23.55% |
| 2017-09-30 | €32.51 Million | €7.32 Million | 0.225x | -- |